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Abstract Human cathepsin W (lymphopain) is a papain-like
cysteine protease of unknown function that is speci¢cally ex-
pressed in natural killer (NK) cells and to a lesser extent in
cytotoxic T cells (CTL). In order to analyze the functional
importance of cathepsin W for the cytotoxic process, we inves-
tigated NK-92 cells that have an NK cell-like phenotype and
express cathepsin W. NK-92 cells possess strong cytotoxic ac-
tivity against Jurkat and K562 cells. The cytotoxic activity of
NK-92 cells against K562 was decreased in the presence of
antisense phosphorothioate oligonucleotides against the cathep-
sin W-cDNA. Western blot analysis showed that the impaired
cytotoxic activity of NK-92 cells was accompanied by reduced
amounts of cathepsin W in the antisense-treated cells. In addi-
tion, co-cultivation experiments between NK-92 and K562 cells
revealed a time-dependent decrease of cathepsin W by Western
blot and immuno£uorescence analysis during the cytotoxic at-
tack, whereas CD56 expression of NK-92 cells was not a¡ected.
During cytotoxic attack, cathepsin W was neither targeted to
K562 cells or other subcellular compartments, as shown by im-
muno£uorescence analysis. The decrease of cathepsin W protein
was associated with stable cathepsin W transcript levels. Con-
trol experiments using HT-29 cells, which are resistant against
NK-92-mediated cytotoxicity, showed no change of cathepsin W
expression, implying that the decrease of cathepsin W in the
NK-92/K562 assay is linked to the cytotoxic process. Although
the exact function of cathepsin W with respect to its enzymatic
activity and its site of action still needs to be elucidated, our
data demonstrate for the ¢rst time that cathepsin W is impor-
tant for cellular cytotoxicity mediated by NK cells.
1 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Cathepsin W (also named lymphopain) represents a cysteine
protease that belongs to the C1A-family of papain-like pro-
teases [1] and was found to be expressed in cytotoxic lympho-
cytes [2,3]. In peripheral blood the majority of the cathepsin
W-expressing cells represent natural killer (NK) cells which
exhibit higher cathepsin W gene expression levels than cyto-
toxic T cells (CTL) [4]. As yet, the proteolytic activity of ca-
thepsin W has not been characterized. Based on restricted
gene expression pattern in cytotoxic cells, a functional role
of cathepsin W in the cytotoxic process mediated by NK cells
and CTL has been suggested [2,4]. Both NK cells and CTL
play a major role in the immune response against tumor cells,
viral infections and allografts [5,6] as well as in in£ammatory
diseases such as arthritis [7], chronic obstructive pulmonary
disease [8] and in£ammatory bowel disease (IBD) [9]. In the
search for a pathophysiological role of cathepsin W, we and
others showed that cathepsin W is di¡erentially expressed in
IBD and autoimmune gastritis [10] and that cathepsin W is
up-regulated in large granular leukemia [11].
To investigate the functional role of cathepsin W in the
cytotoxic process, NK-92 cells, which represent an NK cell
phenotype, were used as a model. Here, we demonstrate
that the antisense-mediated inhibition of cathepsin W leads
to a decrease of cytotoxic activity, and provide further evi-
dence for a functional involvement of cathepsin W in cell-
mediated cytotoxicity.
2. Materials and methods
2.1. Cell culture and treatment with oligonucleotides
NK-92 cells were cultivated in MEM-K containing 12.5% horse
serum, 12.5% fetal calf serum (FCS), 2 mM L-glutamine, 1.5 g/l so-
dium bicarbonate, 0.2 mM inositol, 0.1 mM 2-mercaptoethanol, 0.02
mM folic acid, antibiotics, and 100 U/ml recombinant IL-2 (Pepro-
Tech Inc., USA). K562 and HT-29 cells were cultivated in RPMI-1640
containing antibiotics and 10% FCS. All reagents were purchased
from PAA (Colbe, Germany). For co-cultivation, NK-92 cells and
K562 or HT-29 were mixed at di¡erent cell ratios and incubated in
a 25 cm2 £ask in a cell incubator at 37‡C and 5% CO2 up to 2 h.
For antisense-mediated inhibition of cathepsin W, 1U106 cells were
cultivated in the presence of 10 WM antisense phosphorothioate oli-
gonucleotides (Table 1) for 3 days (8 ml medium) and expanded to 12
ml medium for another 2^3 days. Analyses were performed at day 5
or 6.
2.2. Fluorescence-activated cell sorter (FACS) analysis of NK
cell-mediated cytotoxicity
Cytotoxic assay was performed by a FACS-based method using
K562 as target cells as described by others [12,13]. Brie£y, K562 cells
were split 1 day before testing. Next day, cells were washed with
complete medium and labeled 0.3 WM DiO (3,3P-dioctadecyloxacarbo-
cyanine, a lipophilic membrane dye) in complete medium. E¡ector
cells (NK-92, 2U106/ml) and labeled target cells (K562, 5U105/ml)
were mixed in Falcon polystyrene 12U75 assay tubes to di¡erent
e¡ector:target ratios as well as e¡ector and target cells only. Cells
were centrifuged for 10 min at 200Ug and without removing the
supernatant incubated for 1 h at 37‡C and 5% CO2 in a cell culture
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incubator. After incubation, cells were centrifuged and the pellet was
resuspended in 500 Wl Cell wash (Becton Dickinson, Heidelberg, Ger-
many). The viability of labeled and non-labeled cells was evaluated by
propidiumiodid incorporation (10 Wg/ml). Analysis was performed
using a FACSCalibur £ow cytometer (Becton Dickinson). Cali-
BRITE1 beads (Becton Dickinson) were used for calibration. In or-
der to exclude cell debris from analysis, the threshold was set to
channel 52 of forward scatter on a linear scale. Data acquisition
was performed by the Cellquest software (BDIS). Subsequently, dot
blot combinations of FSC/FL1 (DiO) and FL1/FL3 (DiO/PI) were
created and DiO-positive cells were gated from which at least 2000
cells per sample were examined. The percentage of dead target cells
Table 1
Sequence and localization of antisense oligonucleotides against cathepsin W-cDNA
Name Sequence Position in catW-cDNA
anti-catW 3 5P-ggg-agg-gca-gga-gac-tcg-ggg-ctt-c-3P 1170^1149
anti-catW 4 5P-ggc-cag-gta-ctg-cgc-aat-tc-3P 807^788
anti-catW 5 5P-gag-gct-gag-gct-gag-act-gcg-atg-ga-3P 979^1003
sense catW 3 5P-gaa-gcc-ccg-agt-ctc-ctg-ccc-tcc-g-3P 1149^1170
scrambled catW 3 5P-gag-cga-ggt-acg-gag-ggc-tcg-ct-3P ^
The positions of the oligonucleotides are based on the cDNA sequence (accession number NM_001335 [2].
Fig. 1. FACS-based analysis of cell-mediated cytotoxicity. The assay was performed as described for 90 min using di¡erent ratios of e¡ector
(E) and target (T) cells as indicated in the right margin. The left panel shows dot plots of £uorescence intensity, NK-92 and K562 cells are rep-
resented as black and gray dots (R1), respectively. The right panel represents the corresponding histograms of DiO-positive target cells in R1
documenting viable cells (M1) and dead cells (M2). The relative proportion of killed K562 cells depends on the E/T ratio and time course.
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[FL1: DiO- and FL3: PI-double-positive cells], which re£ects active
cell lysis, was documented in a histogram plot.
2.3. Western blot analysis and quantitative reverse-transcription
polymerase chain reaction (RT-PCR) analysis
Protein extraction, sodium dodecyl sulfate (SDS) electrophoresis
and Western blot analysis were performed by standard methods as
described previously [4]. Cathepsin W was detected using monoclonal
antibody CW40-1B1 [10], the anti-CD56 antibody was obtained from
Chemicon (Temecula, CA, USA). Total cellular RNA was isolated
using the RNeasy kit (Qiagen, Hildesheim, Germany) as described
by the manufacturer, and transcribed into cDNA using a standard
protocol for AMV reverse transcriptase (Promega, Mannheim, Ger-
many). Quantitative RT-PCR was performed using an iCycler (Bio-
Rad, Munich, Germany) in 30 Wl reaction mixture consisting of 15 Wl
HotStartTaq1 Master Mix (Qiagen), 1.2 Wl of the RT reaction,
SYBR-Green I (Molecular Probes, Eugene, OR, USA) and 0.5 WM
of the speci¢c primers for L-actin or cathepsin W using standard
conditions for ampli¢cation. Initial template mRNA amounts were
calculated using the iCycler software. L-Actin mRNA amounts were
used to normalize the cDNA contents of the di¡erent samples. The
following primers were designed for the RT-PCR analysis: Cathepsin
W (Genbank1 accession no. NM001335) fw: 5P-gct-cac-cgc-ctg-gac-
atc-ttg-c-, rev: 5P-tat-gtt-gcc-tgc-cgc-tgc-cat-g-; and L-actin (accession
no. NM001101) fw: 5P-cat-gcc-atc-ctg-cgt-ctg-gac-c-, rev: 5P-aca-tgg-
tgg-tgc-cgc-cag-aca-g. The lengths of the resulting RT-PCR fragments
were 308 bp (cathepsin W) and 400 bp (L-actin).
2.4. Immuno£uorescence analysis
Cells were incubated on polylysine-covered slides at room temper-
ature for 15 min and immediately ¢xed in phosphate-bu¡ered saline
(PBS) (pH 7.4) containing 3.7% PFA and 0.025% glutaraldehyde for
10 min. Cells were permeabilized in PBS containing 0.2% Triton X100
for 10 min, twice rinsed with PBS and blocked with 1% bovine serum
albumin in PBS (pH 7.4) for 20^30 min. Cells were incubated with
primary antibody for 1^2 h and subsequently blocked again as de-
scribed above. Then, specimens were treated with both a secondary
£uorescein isothiocyanate (FITC)-labeled anti-mouse antibody (Sig-
ma) and Rhodamine-succinylated concanavalin A (Vector Laborato-
ries, Burlingame, CA, USA) for 1 h, washed, and post¢xed in PBS
(pH 7.4) containing 3.7% PFA and 0.05% glutaraldehyde for 10 min.
After washing with PBS (pH 7.4), specimens were washed once in PBS
(pH 8.9), and subsequently embedded. The specimens were analyzed
using the £uorescence microscope (Leica DMRE7, Leica Wetzlar,
Germany) equipped with a CCD camera (Spot RT, Diagnostic Instru-
ments, Burroughs, MI, USA) and a 40/1.25 objective. Separate images
were taken in the corresponding channels, and later merged using the
Photoshop1 software. Image acquisition of the controls and data
processing was performed under the same conditions.
3. Results and discussion
3.1. Cell-mediated cytotoxicity of NK-92 cells and cathepsin W
expression
To study the role of cathepsin W, the NK cell-related line
NK-92 was used as a model. NK-92 cells represent large gran-
ular lymphocytic cells with strong cytotoxic activity and NK
cell-like phenotype (CD33, CD43, CD83, CD45þ, CD56þ).
NK-92 cells possess a potent cytotoxic activity against the
erythropoietic cell line K562 and the T-cell line Jurkat. The
rate of cytotoxicity was dose- (Fig. 1) and time-dependent
(data not shown). In addition, NK-92 cells showed a strong
Fig. 2. Cathepsin W gene expression in NK-92 cells during the cytotoxic process. A: Aliquots were harvested between 0 and 120 min as indi-
cated, and subjected to Western blot analysis. The upper blot demonstrates cathepsin W expression of the NK-92/K562 mixture at an E/T ratio
of 2:1. The double band corresponds to the pro-form of cathepsin W at 52^55 kDa. The medium blot shows the corresponding expression of
CD56. The lower panel documents cathepsin W expression of the NK-92/HT-29 mixture at an E/T ratio of 2:1. B: This demonstrates the ca-
thepsin W-mRNA content of NK-92 cells during co-cultivation. Data represent relative values of cathepsin W transcript levels adjusted to time
point 0. The results are shown as mean and standard deviations and represent three to ¢ve independent experiments. C: Indirect immuno£uo-
rescence analysis of cathepsin W was performed using the monoclonal anti-cathepsin W antibody CW40-1B1 detecting the propeptide and a
secondary anti-mouse FITC-labeled antibody (green). Endoplasmic reticulum was stained by Rhodamine-succinylated ConA (Vector Laborato-
ries). Areas of co-localization of both cathepsin W and endoplasmic reticulum are shown in yellow. Controls performed using corresponding
isotype antibody did not show speci¢c staining (data not shown).
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constitutive expression of cathepsin W [10]. In order to inves-
tigate the proposed functional involvement of cathepsin W in
the cytotoxic process, cathepsin W expression was analyzed
during ‘cytotoxic attack’. The co-cultivation of NK-92 and
K562 cells resulted in a reduction of cathepsin W as shown
by Western blot (Fig. 2A) and immuno£uorescence (Fig. 2C).
The strong co-staining with concanavalin A, a lektin that
preferentially binds mannose-glycosylated proteins in the en-
doplasmic reticulum, implies a localization of pro-cathepsin
W in the vicinity of this compartment. The fact that we did
not see any change in the co-localization during the 2 h would
suggest that pro-cathepsin W is not targeted to another com-
partment in NK-92 cells. In order to prove the speci¢city of
the observed down-regulation of pro-cathepsin W, the CD56
expression of NK-92 cells was analyzed by Western blot (Fig.
2A) and immuncytometry. As shown by Western blot (Fig.
2A), CD56 expression of NK-92 cells was unchanged during
‘cytotoxic attack’. The corresponding cyto£uorimetric analysis
of CD56 expression revealed identical results ; both the num-
ber of CD56-expressing cells as well as the CD56 expression
per cell was found to be stable during the co-incubation of 2 h
(data not shown). Furthermore, we investigated the cathepsin
W expression during the co-cultivation of NK-92 cells with
cells that are resistant against NK cell-mediated cytotoxicity.
Interestingly, several cell models (e.g. U937, Raji, Daudi)
known to be resistant against NK cells were e⁄ciently killed
by NK-92 cells (data not shown). Only HT-29 cells, an epi-
thelial cell line derived from colon adenocarcinoma, were
found to be resistant against NK-92 cell-mediated cytotoxic-
ity. During co-cultivation between NK-92 and HT-29 cells,
cathepsin W expression did not change, as shown by Western
blot analysis (Fig. 2A). Together, both control experiments
show that: (I) the ‘down-regulation’ of cathepsin W docu-
mented for NK-92+K562 cells is linked to the cytotoxic ac-
tion, and (II) that this e¡ect is speci¢c for cathepsin W since
CD56 expression was not a¡ected (Fig. 2A).
The analysis of the cathepsin W transcript during co-incu-
bation with K562 cells revealed only a slight increase of ca-
thepsin W-mRNA levels that were not signi¢cantly di¡erent
from those observed in NK-92 cells alone (Fig. 2B). This
¢nding suggests that there is no transcriptional up-regulation
of the cathepsin W gene expression during the ‘cytotoxic at-
tack’. However, it is notable that NK-92 cells are IL-2-depen-
dent, and therefore need to be cultivated in the presence of
Fig. 3. Cell-mediated cytotoxicity of antisense-treated NK-92 cells. A: 5U103 cells were cultivated in 200 Wl medium (96-well plate) in the pres-
ence of 10 WM anti-cathepsin W oligonucleotides 3, 4 and without oligonucleotides (Co) harvested at days 4^6, and subjected to Western blot
analysis. B: Western blot analyses illustrate a partial and slight inhibition of endogenous cathepsin W expression by anti-cathepsin W 3 and
anti-cathepsin W 4+5, respectively (left panel). Both control oligonucleotides (Cs: sense; Crs: randomly scrambled) as well as control without
oligonucleotides (Co) did not a¡ect endogenous cathepsin W expression of NK-92 cells (right panel). C: NK-92 cells were cultivated in the
presence of oligonucleotides as described in Section 2 and their concentration was adjusted to 2U106 cells/ml before analyzing their cytotoxic
activity. The cytotoxic activity of NK-92 cells treated with di¡erent oligonucleotides is shown as relative values (Y-axes) based on the control
without oligonucleotides set to 100%. Data represent mean values and standard deviations of three to ¢ve independent experiments. Values
marked by ‘*’ were found to be signi¢cantly di¡erent from their corresponding controls as analyzed by independent Fisher’s T-test (P6 0.05).
FEBS 27583 11-9-03 Cyaan Magenta Geel Zwart
T. Wex et al./FEBS Letters 552 (2003) 115^119118
IL-2. Since it has been shown that IL-2 induces cathepsin W
gene expression of peripheral NK cells [4], additional e¡ects
on the transcriptional regulation after the ‘cytotoxic attack’
might be prevented in this model.
3.2. Antisense-mediated inhibition of cathepsin W
To investigate the functional importance of cathepsin W
during the cytotoxic process, ¢ve antisense oligonucleotides
were employed to ¢nd out their capability of inhibiting en-
dogenous cathepsin W expression in NK-92 cells. These ex-
periments were performed initially at a small scale (5U103
cells) and revealed three potential candidates that partially
(anti-catW 4 and 5) or completely (anti-catW 3) inhibited ca-
thepsin W expression in NK-92 cells as shown by Western
blot analysis (partially shown in Fig. 3A). For studying cyto-
toxic activity, anti-catW 3, 4 and 5 were used to inhibit ca-
thepsin W expression at a larger scale (1^2U106 cells). Here,
all three oligonucleotides were not as e¡ective as in the small-
scale experiments. Cells treated with anti-catW 3 demon-
strated the strongest inhibition, whereas anti-catW 4 and 5
showed only slight e¡ects on the cellular cathepsin W level
(Fig. 3B). Furthermore, two controls (sense and randomly
scrambled) of the most e¡ective antisense oligonucleotide
anti-catW3 did not signi¢cantly a¡ect cellular cathepsin W
expression (Fig. 3B). The Western blot analyses clearly dem-
onstrated a down-regulation of cathepsin W, in particular by
anti-catW3. To investigate the speci¢city of the antisense-
mediated inhibition, the cathepsin F expression of NK-92 cells
was analyzed. Cathepsin F represents the most closely related
human cathepsin to cathepsin W [14] and could therefore be a
potential target for the anti-cathepsin W antisense oligonu-
cleotides. However, cathepsin F expression was neither de-
tected on the protein or RNA level in these cells (data not
shown). The anti-catW3-mediated inhibition of cathepsin W
resulted in a decrease of cell-mediated cytotoxicity, as shown
in Fig. 3B. Anti-catW 3 signi¢cantly inhibited the cytotoxic
activity of NK-92 cells compared to control oligonucleotides
(Fig. 3B), whereas the two other antisense primers (anti-catW
4+5) did not signi¢cantly di¡er from controls (data not
shown). Altogether, the decrease of endogenous cathepsin W
expression mediated by anti-catW3 corresponded with the im-
paired cytotoxic activity of NK-92 cells.
In summary, the results of our experiments support the
hypothesis that cathepsin W plays an important role in cellu-
lar cytotoxic processes mediated by NK cells. Since the pro-
teolytic activity of cathepsin W has not been identi¢ed, the
underlying mechanism of its functional involvement in the
cytotoxic process is currently unknown. Taking into account
the primary structure of cathepsin W, which has all the fea-
tures of an active cysteine protease, cathepsin W should pos-
sess proteolytic activity. The characterization of its enzymatic
activity as well as the location of its action are key issues to
understand the functional role of cathepsin W.
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